Key Highlights
- Peerbridge Health’s AI-enabled Peerbridge Cor® wearable wins “Best New Technology Solution for Cardiology” at the 2025 MedTech Breakthrough Awards, underscoring innovation in remote cardiac diagnostics.
- The device delivers hospital-grade cardiac monitoring at home, dramatically lowering costs and enabling earlier detection of heart failure and other cardiac conditions.
- Next-gen Cor MDx wearable expands capabilities with real-time streaming and IoT connectivity, enhancing clinical utility and patient access.
AI-Driven Innovation Revolutionizing Cardiac Diagnostics: Peerbridge Health’s Peerbridge Cor® is the first AI-powered wearable bringing hospital-grade cardiac diagnostics directly to patients’ homes. Using patented three-lead AECG technology based on the Einthoven Triangle, it enables early detection of heart failure and other critical cardiac conditions without requiring prior medical history, enhancing diagnostic precision and accessibility.
Award-Winning Technology Validated Through Rigorous Clinical Trials: The Peerbridge Cor® device and platform have been validated through prospective trials confirming their ability to detect heart failure, estimate ejection fraction, and diagnose sleep apnea. Recognition by the prestigious MedTech Breakthrough Awards highlights the platform’s disruptive potential in cardiac care.
Expanding Clinical Utility with Cor MDx: The World’s Most Powerful IoT Cardiac Wearable: The recently launched Cor MDx device offers unmatched signal fidelity, real-time multi-lead streaming, and seamless BLE and LTE connectivity. It broadens clinical applications to over 30 cardiopulmonary indications, enabling continuous patient monitoring and early intervention at a fraction of traditional costs.
Strategic Impact on Healthcare Access and Costs: By delivering cost-effective, remote cardiac diagnostics, Peerbridge Health addresses a critical gap in timely cardiac care access for millions of underserved patients. The AI-driven platform promises to reduce hospital visits, improve patient outcomes, and transform cardiac monitoring into a scalable, patient-centric service model.
About Peerbridge Health
Peerbridge Health is pioneering the future of cardiac care by delivering hospital-grade, AI-enabled cardiac diagnostics and monitoring directly to patients’ homes. Their flagship device, Peerbridge Cor®, leverages patented three-lead AECG technology combined with advanced AI algorithms to enable early detection of heart failure, estimate cardiac function, and diagnose related conditions with high accuracy—without requiring patient medical history. Headquartered in New York, Peerbridge Health is committed to making cardiac care more accessible, affordable, and precise, ultimately improving patient outcomes and reducing healthcare costs globally. For more information, visit peerbridgehealth.com.
By